U.S. biotech firm Bioquark recently got approval to move forward with its ReAnima Project, in which it will try to reverse brain death in patients on life support
U.S. biotech firm Bioquark recently got approval to move forward with its ReAnima Project, in which it will try to reverse brain death in patients on life support